BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23232445)

  • 21. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
    West AR; Grace AA
    J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity.
    Hoque KE; Indorkar RP; Sammut S; West AR
    Psychopharmacology (Berl); 2010 Jan; 207(4):571-81. PubMed ID: 19816675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic inputs to dorsomedial striatum are involved in inhibitory control: evidence from the five-choice serial reaction time task in rats.
    Saund J; Dautan D; Rostron C; Urcelay GP; Gerdjikov TV
    Psychopharmacology (Berl); 2017 Aug; 234(16):2399-2407. PubMed ID: 28451710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats.
    Shi X; McGinty JF
    Psychopharmacology (Berl); 2011 Apr; 214(3):653-63. PubMed ID: 21057772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dopamine D1 receptor blockade in the prelimbic prefrontal cortex or lateral dorsal striatum on frontostriatal function in Wistar and Spontaneously Hypertensive Rats.
    Gauthier JM; Tassin DH; Dwoskin LP; Kantak KM
    Behav Brain Res; 2014 Jul; 268():229-38. PubMed ID: 24755309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons.
    Ma YY; Cepeda C; Chatta P; Franklin L; Evans CJ; Levine MS
    ASN Neuro; 2012 Mar; 4(2):. PubMed ID: 22273000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
    Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
    Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
    Harte M; O'Connor WT
    Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of central amygdala D1 and D2 receptors on attentional performance in a five-choice task.
    Smith ES; Fabian P; Rosenthal A; Kaddour-Djebbar A; Lee HJ
    Behav Neurosci; 2015 Oct; 129(5):564-75. PubMed ID: 26214208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
    Marti M; Mela F; Bianchi C; Beani L; Morari M
    J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task.
    Winstanley CA; Zeeb FD; Bedard A; Fu K; Lai B; Steele C; Wong AC
    Behav Brain Res; 2010 Jul; 210(2):263-72. PubMed ID: 20206211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F; Marti M; Bido S; Cenci MA; Morari M
    Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.
    Quarta D; Naylor CG; Morris HV; Patel S; Genn RF; Stolerman IP
    Neuropharmacology; 2007 Sep; 53(3):421-30. PubMed ID: 17631918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.